Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total glucosides of paeony capsules for moderate and severe dry eye
ChiCTR2200062993Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of total glucosides of paeony in dry eye syndrome (DED) (2 arms), sponsored by Tongji Hospital. Primary endpoints: Ocular surface disease index score, Corneal staining score and 1 more. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
total glucosides of paeony
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2200062993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062993.